Almost every research peptide in the modern catalogue exists because of a chemistry breakthrough that happened in a Rockefeller University lab in 1963. Bruce Merrifield’s idea sounded simple at the time: instead of building a peptide one amino acid at a time in solution — isolating, purifying, and recoupling at each stage — what if you anchored the growing chain to an insoluble bead and just washed reagents through it? That single shift turned peptide chemistry from a months-long art into a programmable process. Sixty years later, every commercial peptide in your freezer was built this way.

The basic architecture

Solid-phase peptide synthesis (SPPS) builds the peptide chain from its C-terminus toward the N-terminus, opposite to how ribosomes build proteins in cells. The C-terminal amino acid is attached to a resin bead through a cleavable linker. Each subsequent amino acid is then added in a repeating cycle. Because the chain is bound to the bead, every wash step removes excess reagents and side products without touching the peptide itself.

One cycle of SPPS consists of three operations:

1. Deprotection — removing the temporary protecting group on the N-terminal amine of the chain so it can react with the next amino acid.
2. Coupling — activating the carboxyl group of the incoming amino acid and forming an amide bond with the deprotected chain.
3. Washing — flushing the resin with solvent to remove excess reagents, by-products, and any residual coupling agents.

Repeat this cycle once per amino acid until the full sequence is built. Then cleave the chain from the bead and remove the side-chain protecting groups in a single global step.

Fmoc versus Boc — the chemistry choice

Two chemistries dominate. Fmoc (9-fluorenylmethyloxycarbonyl) is the modern standard for the vast majority of research peptides. The Fmoc group is removed under mild basic conditions (typically 20% piperidine in DMF) at the start of each cycle. Side chains are protected with acid-labile groups, and the final cleavage uses trifluoroacetic acid (TFA), which removes side-chain protections and releases the peptide from the resin in a single step.

Boc (tert-butyloxycarbonyl) chemistry was the original SPPS approach. It uses acidic deprotection at each cycle (TFA) and a stronger acid (HF or TFMSA) for final cleavage. Boc is still used for peptides that cannot tolerate piperidine conditions or for highly hindered sequences, but its corrosive handling and harsher final cleavage have made Fmoc the default for general work.

Resin choice

The bead matters more than non-chemists usually realize. Wang resin for peptide acids, Rink amide resin for peptide amides, 2-chlorotrityl chloride resin when the C-terminal residue needs to be preserved without epimerization — the choice of resin determines the C-terminal functionality of the final peptide and affects everything from coupling efficiency to cleavage conditions.

Coupling reagents and the long-sequence problem

The amide bond forming reaction needs an activator. The reagent landscape has evolved from early DCC chemistry to modern uronium and phosphonium salts: HBTU, HATU, PyBOP, COMU. Each has trade-offs in coupling speed, racemization control, and cost. HATU, generally considered the most reliable for difficult couplings, is also the most expensive.

For short peptides (under 20 residues), coupling efficiency is rarely the bottleneck. For longer peptides (30+ residues), the cumulative effect of even tiny per-step failures becomes severe. A 99% coupling efficiency over 30 cycles means only 74% of the chains reach completion. That is why long peptides require either pseudoproline dipeptides, microwave-assisted heating, or fragment condensation strategies to avoid difficult coupling regions.

Cleavage and the cocktail

Once the chain is complete, the peptide must be released from the resin and stripped of side-chain protecting groups. The cleavage cocktail is typically TFA (90–95%) plus scavengers: water, triisopropylsilane, ethanedithiol, thioanisole. The scavengers trap reactive carbocations released during deprotection and prevent them from alkylating sensitive side chains (tryptophan, methionine, tyrosine, cysteine).

The choice of scavenger cocktail is sequence-dependent. Cysteine-rich peptides need different protection than tryptophan-heavy sequences. Getting this wrong introduces irreversible side products that downstream HPLC will reveal but cannot remove.

Purification — where the ≥99% number comes from

Crude SPPS product is never pure enough for research use. The crude is typically dissolved, lyophilized, and then purified by preparative reverse-phase HPLC. Fractions are collected, analyzed by analytical HPLC and mass spectrometry, and only those meeting the purity specification are pooled. This is the step that makes ≥99% purity possible. It is also why purity certification has to be lot-specific: each synthesis produces a slightly different distribution of impurities, and each purification pool has its own chromatogram.

Why this matters when ordering peptides

A supplier that controls the synthesis, the cleavage chemistry, and the purification has end-to-end accountability for the final product. A supplier that buys bulk and repackages has none. The questions worth asking are simple: Where was this peptide synthesized? What chemistry was used? Is the final HPLC analysis available with its raw data? The answers separate research-grade peptide chemistry from a relabeled sample of unknown origin.

Related reading: HPLC Verification: Why ≥99% Matters